Parameters associated with outcome in pediatric patients with congenital heart disease and pulmonary hypertension subjected to combined vasodilator and surgical treatments

被引:11
作者
Thomaz, Ana Maria [1 ]
Kajita, Luiz J. [1 ]
Aiello, Vera D. [1 ]
Zorzanelli, Leina [1 ]
Galas, Filomena Regina B. G. [1 ]
Machado, Cleide G. [2 ]
Barbero-Marcial, Miguel [1 ]
Jatene, Marcelo B. [1 ]
Rabinovitch, Marlene [3 ]
Lopes, Antonio Augusto [1 ]
机构
[1] Univ Sao Paulo, Heart Inst, Sch Med, Sao Paulo, Brazil
[2] Univ Sao Paulo, Hosp Clin, Sch Med, Sao Paulo, Brazil
[3] Stanford Univ, Sch Med, Stanford, CA USA
基金
巴西圣保罗研究基金会;
关键词
congenital heart disease; pulmonary hypertension; pediatric cardiac surgery; nitric oxide; sildenafil; ARTERIAL-HYPERTENSION; VASCULAR-RESISTANCE; CHILDREN; SILDENAFIL; REGRESSION; REPAIR; OXYGEN; FLOW;
D O I
10.1177/2045894019837885
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Management of pediatric pulmonary hypertension associated with congenital heart disease (PHT-CHD) is challenging. Some patients have persistently elevated pulmonary artery pressure (PAP) after cardiac surgery, an undesired condition that is difficult to predict. We investigated the value of clinical, hemodynamic, and histopathological data in predicting the outcome in a prospective cohort. Patients with PHT-CHD received sildenafil orally pre- and postoperatively for six months and then were subjected to a catheter study. Thirty-three patients were enrolled (age range = 4.6-37.0 months). Pulmonary vascular resistance (PVR) was 4.9 (range = 3.9-7.2) Wood units x m(2) (median with IQR). Twenty-two patients had a >= 20% decrease in PVR and pulmonary-to-systemic vascular resistance ratio (PVR/SVR) in response to inhaled nitric oxide (NO). The response was directly related to the degree of medial hypertrophy of pulmonary arterioles (P < 0.05) (morphometric analysis, intraoperative lung biopsy). Subsequently, five of the non-responders had a >= 30% increase in pulmonary blood flow in response to sildenafil (3.0 [2.0-4.0] mg/kg/day). Six months after surgery, PAP and PVR were significantly lower (P < 0.001 vs. baseline), even in seven patients with Heath-Edwards grade III/IV pulmonary vascular lesions (P = 0.018), but still abnormal in 12 individuals (>25 mmHg and >3.0 U x m(2), respectively). A preoperative PVR/SVR of >= 24% during NO inhalation and a wall thickness of arteries accompanying respiratory bronchioli of >= 4.7 (Z score) were identified, respectively, as risk and protection factors for abnormal postoperative hemodynamics (hazard ratio [95% CI] = 1.09 [1.01-1.18], P = 0.036; and 0.69 [0.49-0.98], P = 0.040, respectively). Thus, in PHT-CHD patients receiving oral sildenafil pre- and post-surgical repair of cardiac lesions, mid-term postoperative outcome is predictable to some extent.
引用
收藏
页数:13
相关论文
共 27 条
[1]   Haemodynamic unloading reverses occlusive vascular lesions in severe pulmonary hypertension [J].
Abe, Kohtaro ;
Shinoda, Masako ;
Tanaka, Mariko ;
Kuwabara, Yukimitsu ;
Yoshida, Keimei ;
Hirooka, Yoshitaka ;
McMurtry, Ivan F. ;
Oka, Masahiko ;
Sunagawa, Kenji .
CARDIOVASCULAR RESEARCH, 2016, 111 (01) :16-25
[2]   Pediatric Pulmonary Hypertension Guidelines From the American Heart Association and American Thoracic Society [J].
Abman, Steven H. ;
Hansmann, Georg ;
Archer, Stephen L. ;
Ivy, D. Dunbar ;
Adatia, Ian ;
Chung, Wendy K. ;
Hanna, Brian D. ;
Rosenzweig, Erika B. ;
Raj, J. Usha ;
Cornfield, David ;
Stenmark, Kurt R. ;
Steinhorn, Robin ;
Theobaud, Bernard ;
Fineman, Jeffrey R. ;
Kuehne, Titus ;
Feinstein, Jeffrey A. ;
Friedberg, Mark K. ;
Earing, Michael ;
Barst, Robyn J. ;
Keller, Roberta L. ;
Kinsella, John P. ;
Mullen, Mary ;
Deterding, Robin ;
Kulik, Thomas ;
Mallory, George ;
Humpl, Tilman ;
Wessel, David L. .
CIRCULATION, 2015, 132 (21) :2037-2099
[3]   Inhaled nitric oxide as a preoperative test (INOP Test I) - The INOP Test Study Group [J].
Balzer, DT ;
Kort, HW ;
Day, RW ;
Corneli, HM ;
Kovalchin, JP ;
Cannon, BC ;
Kaine, SF ;
Ivy, DD ;
Webber, SA ;
Rothman, A ;
Ross, RD ;
Aggarwal, S ;
Takahashi, M ;
Waldman, JD .
CIRCULATION, 2002, 106 (13) :I76-I81
[4]   Can "Inoperable" Congenital Heart Defects Become Operable in Patients with Pulmonary Arterial Hypertension? Dream or Reality? [J].
Beghetti, Maurice ;
Galie, Nazzareno ;
Bonnet, Damien .
CONGENITAL HEART DISEASE, 2012, 7 (01) :3-11
[5]   Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure [J].
El Midany, Ashraf A. H. ;
Mostafa, Ezzeldin A. ;
Azab, Sherif ;
Hassan, Ghada A. .
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 17 (06) :963-968
[6]   Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease [J].
Fraisse, Alain ;
Butrous, Ghazwan ;
Taylor, Mary B. ;
Oakes, Michael ;
Dilleen, Maria ;
Wessel, David L. .
INTENSIVE CARE MEDICINE, 2011, 37 (03) :502-509
[7]   2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) [J].
Galie, Nazzareno ;
Humbert, Marc ;
Vachiery, Jean-Luc ;
Gibbs, Simon ;
Lang, Irene ;
Torbicki, Adam ;
Simonneau, Gerald ;
Peacock, Andrew ;
Noordegraaf, Anton Vonk ;
Beghetti, Maurice ;
Ghofrani, Ardeschir ;
Gomez Sanchez, Miguel Angel ;
Hansmann, Georg ;
Klepetko, Walter ;
Lancellotti, Patrizio ;
Matucci, Marco ;
McDonagh, Theresa ;
Pierard, Luc A. ;
Trindade, Pedro T. ;
Zompatori, Maurizio ;
Hoeper, Marius .
EUROPEAN HEART JOURNAL, 2016, 37 (01) :67-+
[8]   Preoperative pulmonary hemodynamics and assessment of operability: Is there a pulmonary vascular resistance that precludes cardiac operation? [J].
Giglia, Therese M. ;
Humpl, Tilman .
PEDIATRIC CRITICAL CARE MEDICINE, 2010, 11 :S57-S69
[9]   Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006 [J].
Haworth, S. G. ;
Hislop, A. A. .
HEART, 2009, 95 (04) :312-317
[10]   PULMONARY VASCULAR DEVELOPMENT - NORMAL VALUES OF PERIPHERAL VASCULAR STRUCTURE [J].
HAWORTH, SG ;
HISLOP, AA .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (05) :578-583